SARTF (Sartorius AG) Ending Cash Position: $663 Mil (As of Mar. 2026)


SARTF Sartorius AG SARTF
85 GF Score
Price $212.80
GF Value $273.53
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Sartorius AG Ending Cash Position?

Sartorius AG SARTF 85 Ending Cash Position is $663 Mil as of Mar. 2026. GuruFocus rates SARTF with a GF Score™ of 85/100 and a GF Value™ of $273.53 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Sartorius AG's Ending Cash Position for the quarter that ended in Mar. 2026 was $663 Mil.

Sartorius AG's quarterly Ending Cash Position increased from Sep. 2025 ($458 Mil) to Dec. 2025 ($634 Mil) and increased from Dec. 2025 ($634 Mil) to Mar. 2026 ($663 Mil).

Sartorius AG's annual Ending Cash Position increased from Dec. 2023 ($414 Mil) to Dec. 2024 ($852 Mil) but then declined from Dec. 2024 ($852 Mil) to Dec. 2025 ($634 Mil).


Sartorius AG Ending Cash Position Related Terms


Sartorius AG Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Sartorius AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG Ending Cash Position Chart

Sartorius AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 387.35 175.74 413.52 851.73 633.96

Sartorius AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 907.57 944.64 457.63 633.96 663.35
SARTF
85GF Score
Sartorius AG SARTF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sartorius AG's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=952.459+-318.501
=634

Sartorius AG's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=625.896+37.457
=663

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $663 Mil mean?
Sartorius AG (SARTF) has a Ending Cash Position of $663 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sartorius AG and its competitors.
Is Sartorius AG's Ending Cash Position too high?
Sartorius AG's current Ending Cash Position is $663 Mil. Overall, Sartorius AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Ending Cash Position compare to ISRG and BDX?
Sartorius AG's Ending Cash Position of $663 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sartorius AG and its competitors. Sartorius AG's current Ending Cash Position is $663 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (SARTF) is currently considered Modestly Undervalued. The stock's GF Value™ is $273.53, compared to a current price of $212.80 — trading 22.2% below its estimated fair value. The current Ending Cash Position is $663 Mil. Sartorius AG's overall GF Score™ is 85/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Sartorius AG (SARTF), the current Ending Cash Position is $663 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius AG (SARTF) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued. The current stock price of $212.80 is trading 22.2% below its estimated GF Value™ of $273.53. GuruFocus considers Sartorius AG to be Modestly Undervalued.

Key valuation signals for SARTF:

  • Ending Cash Position: $663 Mil
  • GF Value™: $273.53 vs. price of $212.80 (22.2% below fair value)
  • GF Score™: 85/100 with 10 warning signs

No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
85GF Score

Get the complete analysis for SARTF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$212.80
Price
$273.53
GF Value